The device was not returned for analysis.A review of the lot history record identified no manufacturing nonconformities issued to the reported lot that would have contributed to the reported event.Additionally, a review of the complaint history identified no other complaints from the lot.All available information was investigated, and the reported slda associated with the clip detaching from the posterior leaflet per the physician is related to poor tissue integrity and therefore related to patient conditions.Unspecified tissue injury and mitral valve insufficiency/regurgitation appear to be related to the slda.Tissue damage and mitral regurgitation are listed in the instructions for use (ifu) as known possible complications associated with mitraclip procedures.Unexpected medical intervention and hospitalization were a result of case-specific circumstances.There is no indication of a product issue with respect to manufacture, design or labeling.
|
It was reported that on (b)(6) 2024, a patient presented with grade 4 functional mitral regurgitation, posterior chord restriction, and unhealthy tissue for a mitraclip procedure.One mitraclip xtw (lot: 31016r1007) was implanted and the mr was reduced to grade 1.On (b)(6) 2024, the patient returned with a single leaflet device attachment (slda) and recurrent mr grade 1+.Per the physician, the slda was due to poor tissue integrity.Tissue damage was observed.A second clip intervention was performed to stabilize the slda.A ntw mitraclip (lot: 30607a1025) was implanted however, mr remained unchanged at grade 1+.
|